A case of remarkable response to atezolizumab in ALK-translocated metastatic lung adenocarcinoma
The development of resistance to tyrosine kinase inhibitors (TKIs) in metastatic non-small cell lung cancer (NSCLC) with oncogenic driver mutations highlights the challenge in improving the survival of these patients. The standard of care for ALK-rearranged advanced NSCLC refractory to various gener...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Published: |
Elsevier
2021
|
| Subjects: | |
| Online Access: | http://eprints.um.edu.my/34895/ |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|